Jansson-Löfmark R, Römsing S, Albers E, Ashton M
Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Göteborg, Sweden.
Biomed Chromatogr. 2010 Jul;24(7):768-73. doi: 10.1002/bmc.1361.
A bioanalytical method for indirect determination of eflornithine enantiomers in 75 microL human plasma has been developed and validated. L- and D-eflornithine were derivatized with o-phthalaldehyde and N-acetyl-L-cysteine to generate diastereomers which were separated on two serially connected Chromolith Performance columns (RP-18e 100 x 4.6 mm i.d.) by a isocratic flow followed by a gradient flow for elution of endogenous compounds. The diastereomers were detected with UV (340 nm). The between-day precisions for L- and D-eflornithine in plasma were 8.4 and 2.3% at 3 microm, 4.0 and 5.1% at 400 microm, and 2.0 and 3.7% at 1000 microm. The lower limit of quantification was determined to be 1.5 microm, at which precision was 14.9 and 9.9% for L- and D-eflornithine, respectively.
已开发并验证了一种用于间接测定75微升人血浆中依氟鸟氨酸对映体的生物分析方法。L-依氟鸟氨酸和D-依氟鸟氨酸用邻苯二甲醛和N-乙酰-L-半胱氨酸进行衍生化,生成非对映异构体,这些非对映异构体在两根串联的Chromolith Performance柱(RP-18e 100×4.6毫米内径)上通过等度洗脱,然后用梯度洗脱内源性化合物的流动相进行分离。用紫外(340纳米)检测非对映异构体。血浆中L-依氟鸟氨酸和D-依氟鸟氨酸的日间精密度在3微摩尔时分别为8.4%和2.3%,在400微摩尔时分别为4.0%和5.1%,在1000微摩尔时分别为2.0%和3.7%。定量下限确定为1.5微摩尔,此时L-依氟鸟氨酸和D-依氟鸟氨酸的精密度分别为14.9%和9.9%。